Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Neurocrine Biosciences Inc (NBIX) vs Tidewater Inc (TDW) Price & Performance

Neurocrine Biosciences IncTrade
Tidewater IncTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Tidewater Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Tidewater Inc trades at $78.18 (market cap $3.75B). The key difference: Neurocrine Biosciences Inc is far larger — about 4.6× Tidewater Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Tidewater Inc nearer its low. Which is the better fit depends on your goals.

NBIXTDW
Market Cap
$17.40B$3.75B
Sector
HealthUtilities
52-Week High
$180.55$91.12
52-Week Low
$123.10$47.29
Enterprise Value
$16.49B$3.85B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX

About Tidewater Inc

Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.

Read more on TDW